Fatigue, cognitive changes and sleep disturbances were as important to patients with early Parkinson’s disease as symptoms ...
This is why the new funding matters. It allows Cellbricks Therapeutics to move beyond promise and into proof: to show that engineered human tissues can perform in clinically relevant models and to ...
Oryon Cell Therapies (“Oryon”), a clinical-stage biotechnology company focused on developing autologous neuron replacement ...
It's my pleasure to be moderating this chat with the CEO of Voyager Therapeutics, Al Sandrock, who sure many folks know well from his current role and famous roles as prior. Al, maybe we can get into ...
Dosed multiple Rett syndrome patients in REVEAL pivotal trial of TSHA-102, with enrollment advancing across multiple sites; on track to complete dosing in Q2 2026 Received FDA clearance to initiate ...
The voter-approved Nebraska Medical Cannabis Commission is banking on the Legislature to pass the state’s first-ever bill related to a medical cannabis program as a key step toward a regulated, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results